Beijing Kawin Technology Share-holding Co Ltd
SSE:688687

Watchlist Manager
Beijing Kawin Technology Share-holding Co Ltd Logo
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Watchlist
Price: 23.1 CNY 0.92% Market Closed
Market Cap: 3.9B CNY
Have any thoughts about
Beijing Kawin Technology Share-holding Co Ltd?
Write Note

Beijing Kawin Technology Share-holding Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Beijing Kawin Technology Share-holding Co Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Interest Income Expense
ÂĄ26.9m
CAGR 3-Years
94%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Interest Income Expense
-ÂĄ59.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Interest Income Expense
-ÂĄ159m
CAGR 3-Years
-2%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Interest Income Expense
ÂĄ217.7m
CAGR 3-Years
N/A
CAGR 5-Years
134%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Interest Income Expense
-ÂĄ66.3m
CAGR 3-Years
-3%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Interest Income Expense
ÂĄ78.6m
CAGR 3-Years
37%
CAGR 5-Years
99%
CAGR 10-Years
N/A
No Stocks Found

Beijing Kawin Technology Share-holding Co Ltd
Glance View

Market Cap
3.9B CNY
Industry
Biotechnology

Beijing Kawin Technology Share-Holding Co., Ltd. provides biotechnology treatment solutions and medicines. The company is headquartered in Beijing, Beijing and currently employs 647 full-time employees. The company went IPO on 2021-02-08. The firm's recombinant human interferon α2b and compound glycyrrhizin drugs are applied to treat viral diseases. The firm mainly distributes its products within domestic market.

Intrinsic Value
26.97 CNY
Undervaluation 14%
Intrinsic Value
Price

See Also

What is Beijing Kawin Technology Share-holding Co Ltd's Interest Income Expense?
Interest Income Expense
26.9m CNY

Based on the financial report for Dec 31, 2023, Beijing Kawin Technology Share-holding Co Ltd's Interest Income Expense amounts to 26.9m CNY.

What is Beijing Kawin Technology Share-holding Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
54%

Over the last year, the Interest Income Expense growth was -10%. The average annual Interest Income Expense growth rates for Beijing Kawin Technology Share-holding Co Ltd have been 94% over the past three years , 54% over the past five years .

Back to Top